Skip to content

Since 2007

Page 753 of 784

The Archive

More than 14,000 stories on food, diet and health, newest first.

FDA granted tentative approval to Matrix Laboratories' fixed-dose abacavir, lamivudine and zidovudine tablet for treating HIV-1 in adults. Patent rights bar US marketing, but the tablet becomes eligible for purchase under PEPFAR, and fixed-dose tablets cut pill burden and may aid adherence.

1 min read

14095 stories